96 related articles for article (PubMed ID: 9619817)
1. HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia.
Hengge UR; Brockmeyer NH; Esser S; Maschke M; Goos M
AIDS; 1998 May; 12(7):818-20. PubMed ID: 9619817
[No Abstract] [Full Text] [Related]
2. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
[TBL] [Abstract][Full Text] [Related]
3. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
[TBL] [Abstract][Full Text] [Related]
4. CSF amyloid beta42 and tau levels correlate with AIDS dementia complex.
Brew BJ; Pemberton L; Blennow K; Wallin A; Hagberg L
Neurology; 2005 Nov; 65(9):1490-2. PubMed ID: 16275845
[TBL] [Abstract][Full Text] [Related]
5. Viral load in HIV-associated dementia.
Glass JD; Wesselingh SL
Ann Neurol; 1998 Jul; 44(1):150-1. PubMed ID: 9667609
[No Abstract] [Full Text] [Related]
6. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.
Letendre SL; Lanier ER; McCutchan JA
J Infect Dis; 1999 Aug; 180(2):310-9. PubMed ID: 10395844
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.
Enting RH; Prins JM; Jurriaans S; Brinkman K; Portegies P; Lange JM
Clin Infect Dis; 2001 Apr; 32(7):1095-9. PubMed ID: 11264039
[TBL] [Abstract][Full Text] [Related]
9. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load?
Perrella O; Carreiri PB; Perrella A; Sbreglia C; Gorga F; Guarnaccia D; Tarantino G
Eur Cytokine Netw; 2001 Mar; 12(1):51-5. PubMed ID: 11282546
[TBL] [Abstract][Full Text] [Related]
11. CSF, plasma viral load and HIV associated dementia.
Robertson K; Fiscus S; Kapoor C; Robertson W; Schneider G; Shepard R; Howe L; Silva S; Hall C
J Neurovirol; 1998 Feb; 4(1):90-4. PubMed ID: 9531015
[TBL] [Abstract][Full Text] [Related]
12. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
Gisslen M; Hagberg L; Brew BJ; Cinque P; Price RW; Rosengren L
J Infect Dis; 2007 Jun; 195(12):1774-8. PubMed ID: 17492593
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid HIV load in diverse clinical circumstances.
Jenny-Avital ER; Hoffman J; Katz M; Leider J; Apfelroth S
Clin Infect Dis; 2008 Jun; 46(12):1938-40; author reply 1940-1. PubMed ID: 18540816
[No Abstract] [Full Text] [Related]
14. Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system.
Delforge ML; Farber CM; De Leener F; Caroyer JM; Liesnard C; Van Vooren JP
Clin Infect Dis; 1999 Apr; 28(4):931. PubMed ID: 10825078
[No Abstract] [Full Text] [Related]
15. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
[TBL] [Abstract][Full Text] [Related]
17. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.
Tambussi G; Gori A; Capiluppi B; Balotta C; Papagno L; Morandini B; Di Pietro M; Ciuffreda D; Saracco A; Lazzarin A
Clin Infect Dis; 2000 Jun; 30(6):962-5. PubMed ID: 10880317
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of high levels of HIV-1 RNA in the cerebrospinal fluid (CSF) using amplicor HIV-1 monitor test.
Honderlick P; Zucman D; Couderc LJ
Pathol Biol (Paris); 1999 May; 47(5):560-2. PubMed ID: 10418040
[TBL] [Abstract][Full Text] [Related]
19. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
20. Neurological efficacy of stavudine, zidovudine, and lamivudine.
Brew BJ
Lancet; 1998 Aug; 352(9125):402. PubMed ID: 9717950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
